<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
PRPH
ProPhase Labs
$
()


  • ProPhase Labs rating moved to under review at H.C. Wainwright

    3/19/2024 - 10:38am
  • ProPhase Labs sees significant sequential improvement in revenues going forward

    3/15/2024 - 08:13am
  • ProPhase Labs reports 2023 EPS (98c) vs. $1.02 last year

    3/15/2024 - 08:11am
  • ProPhase Labs announces significant progress in BE-SMART test development

    2/20/2024 - 08:15am
  • ProPhase Labs announces preliminary results for dietary supplement Equivir

    2/14/2024 - 08:23am
  • ProPhase Labs announces Karkus became President of Nebula Genomics

    1/30/2024 - 08:15am
  • ProPhase Labs announces significant progress at PMI

    1/23/2024 - 08:12am
  • ProPhase Labs appoints Latkin as COO

    1/4/2024 - 08:08am
  • ProPhase Labs price target lowered to $11 from $14 at H.C. Wainwright

    11/10/2023 - 10:08am
  • ProPhase Labs reports Q3 EPS (30c) vs 6c last year

    11/9/2023 - 08:09am
  • ProPhase Labs announces growth expectations for Pharmaloz

    10/17/2023 - 08:11am
  • DSS CEO looking forward to 'significant growth' for remainder of the year

    10/12/2023 - 08:30am
  • ProPhase Labs reports Q2 EPS (20c) vs. 40c last year

    8/10/2023 - 08:12am
  • ProPhase Labs partners with Certis Oncology for Linebacker-1

    8/3/2023 - 08:21am
  • Navidea board rejects on-binding offer from ProPhase Labs

    6/30/2023 - 09:21am
dynamic_feed Breaking News